Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284
What this trial is testing
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Rutgers, The State University of New Jersey 90